Literature DB >> 35059811

[This is how I treat-Polymyalgia rheumatica with a cumulative dosage of glucocorticoids as low as possible].

Jens Gert Kuipers1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35059811     DOI： 10.1007/s00393-022-01157-w

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN： 0340-1855            Impact factor:   1.372


× No keyword cloud information.
  19 in total

1.  Increased frequency of malignancy found in patients presenting with new-onset polymyalgic symptoms suggested to have polymyalgia rheumatica.

Authors:  Glenn Haugeberg; H Dovland; V Johnsen
Journal:  Arthritis Rheum       Date:  2002-06-15

Review 2.  Giant cell arteritis, polymyalgia rheumatica, and late-onset rheumatoid arthritis: Can they be components of a single disease process in elderly patients?

Authors:  Cengiz Korkmaz; Pınar Yıldız
Journal:  Eur J Rheumatol       Date:  2017-02-24

Review 3.  [S3 guidelines on treatment of polymyalgia rheumatica : Evidence-based guidelines of the German Society of Rheumatology (DGRh), the Austrian Society of Rheumatology and Rehabilitation (ÖGR) and the Swiss Society of Rheumatology (SGT) and participating medical scientific specialist societies and other organizations].

Authors:  F Buttgereit; T Brabant; H Dinges; I Hiemer; M Kaplani; U Kiltz; D Kyburz; A Reißhauer; M Schneider; C Weseloh; C Dejaco
Journal:  Z Rheumatol       Date:  2018-06       Impact factor: 1.372

4.  Treatment of polymyalgia rheumatica and giant cell arteritis. I. Steroid regimens in the first two months.

Authors:  V Kyle; B L Hazleman
Journal:  Ann Rheum Dis       Date:  1989-08       Impact factor: 19.103

5.  No increased frequency of malignant neoplasms in polymyalgia rheumatica and temporal arteritis. A prospective longitudinal study of 398 cases and matched population controls.

Authors:  Geirmund Myklebust; Tom Wilsgaard; Bjarne Koster Jacobsen; Jan Tore Gran
Journal:  J Rheumatol       Date:  2002-10       Impact factor: 4.666

6.  Erythrocyte sedimentation rate and C-reactive protein in the evaluation of disease activity and severity in polymyalgia rheumatica: a prospective follow-up study.

Authors:  F Cantini; C Salvarani; I Olivieri; L Macchioni; A Ranzi; L Niccoli; A Padula; L Boiardi
Journal:  Semin Arthritis Rheum       Date:  2000-08       Impact factor: 5.532

7.  A polymyalgia rheumatica-like syndrome as presentation of metastatic cancer.

Authors:  J E Naschitz; G Slobodin; D Yeshurun; M Rozenbaum; I Rosner
Journal:  J Clin Rheumatol       Date:  1996-12       Impact factor: 3.517

Review 8.  Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review.

Authors:  Frank Buttgereit; Christian Dejaco; Eric L Matteson; Bhaskar Dasgupta
Journal:  JAMA       Date:  2016-06-14       Impact factor: 56.272

9.  EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update.

Authors:  Josef S Smolen; Robert B M Landewé; Johannes W J Bijlsma; Gerd R Burmester; Maxime Dougados; Andreas Kerschbaumer; Iain B McInnes; Alexandre Sepriano; Ronald F van Vollenhoven; Maarten de Wit; Daniel Aletaha; Martin Aringer; John Askling; Alejandro Balsa; Maarten Boers; Alfons A den Broeder; Maya H Buch; Frank Buttgereit; Roberto Caporali; Mario Humberto Cardiel; Diederik De Cock; Catalin Codreanu; Maurizio Cutolo; Christopher John Edwards; Yvonne van Eijk-Hustings; Paul Emery; Axel Finckh; Laure Gossec; Jacques-Eric Gottenberg; Merete Lund Hetland; Tom W J Huizinga; Marios Koloumas; Zhanguo Li; Xavier Mariette; Ulf Müller-Ladner; Eduardo F Mysler; Jose A P da Silva; Gyula Poór; Janet E Pope; Andrea Rubbert-Roth; Adeline Ruyssen-Witrand; Kenneth G Saag; Anja Strangfeld; Tsutomu Takeuchi; Marieke Voshaar; René Westhovens; Désirée van der Heijde
Journal:  Ann Rheum Dis       Date:  2020-01-22       Impact factor: 19.103

10.  2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.

Authors:  Christian Dejaco; Yogesh P Singh; Pablo Perel; Andrew Hutchings; Dario Camellino; Sarah Mackie; Andy Abril; Artur Bachta; Peter Balint; Kevin Barraclough; Lina Bianconi; Frank Buttgereit; Steven Carsons; Daniel Ching; Maria Cid; Marco Cimmino; Andreas Diamantopoulos; William Docken; Christina Duftner; Billy Fashanu; Kate Gilbert; Pamela Hildreth; Jane Hollywood; David Jayne; Manuella Lima; Ajesh Maharaj; Christian Mallen; Victor Martinez-Taboada; Mehrdad Maz; Steven Merry; Jean Miller; Shunsuke Mori; Lorna Neill; Elisabeth Nordborg; Jennifer Nott; Hannah Padbury; Colin Pease; Carlo Salvarani; Michael Schirmer; Wolfgang Schmidt; Robert Spiera; David Tronnier; Alexandre Wagner; Madeline Whitlock; Eric L Matteson; Bhaskar Dasgupta
Journal:  Ann Rheum Dis       Date:  2015-10       Impact factor: 19.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.